Two-year results of a combined regimen of aflibercept treatment in three types of choroidal neovascular membrane in the wet form of age-related macular degeneration: Real-life evidence in the Czech Republic

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F20%3AA22029TQ" target="_blank" >RIV/61988987:17110/20:A22029TQ - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/21:10419203 RIV/00064190:_____/20:N0000124 RIV/00216208:11120/21:43920784 RIV/00843989:_____/21:E0109290 and 2 more
Result on the web
<a href="https://journals.sagepub.com/doi/pdf/10.1177/1120672120971190" target="_blank" >https://journals.sagepub.com/doi/pdf/10.1177/1120672120971190</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1177/1120672120971190" target="_blank" >10.1177/1120672120971190</a>

Result language
angličtina
Original language name
Two-year results of a combined regimen of aflibercept treatment in three types of choroidal neovascular membrane in the wet form of age-related macular degeneration: Real-life evidence in the Czech Republic
Original language description
To present the results of a 2-year therapy with aflibercept in real-life practice in a mixed regimen in patients with a neovascular form of age-related macular degeneration (nAMD) and to evaluate the treatment response of various types of choroidal neovascular membranes (CNV) – occult (Type 1), classic (Type 2) and minimally classic (Type 4).
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30207 - Ophthalmology

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)